Outcome of Board Meeting
Outcome of Board Meeting held today i.e on 23rd May, 201723-05-2017
A Meeting Of The Board Of Directors Has Been Scheduled To Be Held On Tuesday, May 23, 2017 At B-1/E-24, Mohan Co-Operative Industrial Area, Mathura Road, New Delhi-110044 At 2:00 P.M
This is to intimate pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors has been scheduled to be held on Tuesday, May 23, 2017 at B-1/E-24, Mohan Co-Operative Industrial Area, Mathura Road, New Delhi-110044 at 2:00 P.M. to inter-alia, consider, approve and take on record the Audited financial results of the Company for the fourth quarter and year ended 31st...15-05-2017
JHS Svendgaard Labs settles disputes with Procter & Gamble India
JHS Svendgaard Laboratories says the ongoing disputes at various courts between the company and Procter & Gamble in India have been settled with mutual consent24-04-2017
Updates
This is to inform that the on-going disputes at various courts between the company (JHS Svendgaard) and various group companies of Procter & Gamble Inc. in India, have been settled with mutual consent and concluded positively for JHS24-04-2017
Shareholding for the Period Ended March 31, 2017
JHS Svendgaard Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here17-04-2017
Compliance Certificate From Compliance Officer & RTA For The Half Year Ended 31St March, 2017
Submission of Compliance Certificate from Compliance Officer & RTA for the half year ended 31st March, 2017 as per Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.13-04-2017
Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Submission of Compliance Certificate under Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 issued by the Practicing Company Secretary for the half year ended 31st March, 2017.13-04-2017
Statement Of Investors Complaint For The Quarter Ended 31St March, 2017.
The Quarterly Compliance Status of Investor Complaint under Regulation 13(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for the quarter ended 31st March, 2017.13-04-2017
Statement of Deviation & Variation for Quarter Ended December 31, 2016
JHS Svendgaard Laboratories Ltd has submitted to BSE a copy of Statement of Deviation & Variation for Third Quarter Ended December 31, 2016.14-02-2017
Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016
JHS Svendgaard Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Consolidated Financial Results for the period ended December 31, 20163. Standalone Limited Review for the period ended December 31, 20164. Consolidated Limited Review for the period ended December 31, 201613-02-2017